Northwestern Study Shows 17 Lung Transplants Beat Standard Care in Stage 4 Cancer
Updated
Updated · STAT · Jul 8
Northwestern Study Shows 17 Lung Transplants Beat Standard Care in Stage 4 Cancer
3 articles · Updated · STAT · Jul 8
Summary
JAMA data from Northwestern showed 17 patients with stage 4 lung cancer confined to the lungs outlived 81 similar patients on standard therapy, challenging a long-standing transplant taboo.
At one year through June 2025, all 17 transplant recipients were alive versus 88% of noncancer transplant patients; among the 81 on standard care, 74 had disease progression.
By January 2026, the transplant group had four cancer recurrences and two non-cancer deaths, while surgeons credited strict selection, modern chemo-immunotherapy and Covid-era techniques for removing diseased lungs wholesale.
About 300 U.S. patients a year may fit this narrow profile, but outside experts said wider adoption needs larger randomized trials because each donated lung used for cancer is unavailable to another recipient.
A new transplant gives terminal lung cancer patients 100% one-year survival. Is this a cure or false hope?
Is it ethical to give scarce donor lungs to Stage 4 cancer patients over others on the transplant list?
After removing cancerous lungs, what stops the highly resistant cancer cells from returning elsewhere in the body?
100% One-Year Survival After Lung Transplantation for Select Stage IV Lung Cancer: The Northwestern DREAM Study’s Groundbreaking Results and Implications
Overview
The Northwestern Medicine DREAM study, published in JAMA in July 2026, marks a major shift in lung cancer treatment by challenging the belief that stage IV non-small cell lung cancer (NSCLC) is always incurable. This landmark research explored lung transplantation as an option for a very select group of patients—those 65 or younger, with stable, limited cancer spread, no lymph node involvement, and no other major health issues. By carefully choosing 17 patients who met these strict criteria, the study showed that, for some, lung transplantation could offer new hope and potentially redefine what is possible for advanced lung cancer care.